KYXINKO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

KYXINKO Trademark

Serial Number: 79300480 • Registration: 6848725

KYXINKO is a trademark filed by LABORATORIOS FARMACEUTICOS ROVI, S.A. on November 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LABORATORIOS FARMACEUTICOS ROVI, S.A.

C/ Julián Camarillo, 35

Entity Type: 85

Trademark Details

Filing Date

November 6, 2020

Registration Date

September 20, 2022

Published for Opposition

July 5, 2022

Goods & Services

Pharmaceutical products, namely, antibiotics, analgesics, anesthetics for surgical and non-surgical use, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, prescription synthetic narcotics; chemical products for medical use, namely, pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes, all sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticals, namely, oncological preparations for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergies, for disorders of the skin, thrombosis, coagulation diseases, infections, flu, pain and inflammation; tranquilizers, prescription synthetic narcotics, antidepressants, anxiolytics; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2026 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 15, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 22, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 22, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 20, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 20, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 20, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jul 5, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 5, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 15, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 15, 2022 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 12, 2022 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 30, 2022 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 25, 2022 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2022 TROA
REFUSAL PROCESSED BY IB
Mar 13, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 24, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 24, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 29, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 28, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 15, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 11, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 7, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR